Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Denileukin diftitox.

M Saxon1

  • 1Cancer Centers of the Carolinas, Seneca, SC, USA.

Clinical Journal of Oncology Nursing
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Primary cutaneous T-cell lymphomas (CTCLs) are rare skin cancers. While early stages offer a normal life expectancy, transformation to large cell lymphoma significantly worsens prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selected symposia.

IDrugs : the investigational drugs journal·2005
Same author

Poster and slide session II.

IDrugs : the investigational drugs journal·2005
Same author

Global Resistance Day.

IDrugs : the investigational drugs journal·2005
Same author

The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system.

Journal of virology·1999
Same author

Adaptations of myocardial beta-adrenergic receptor complex in hibernating marmots.

The American journal of physiology·1993
Same author

Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.

Proceedings of the National Academy of Sciences of the United States of America·1993

Area of Science:

  • Dermatology
  • Oncology
  • Hematology

Background:

  • Primary cutaneous T-cell lymphomas (CTCLs) are a diverse group of rare skin-localized lymphomas.
  • Mycosis fungoides and Sezary syndrome represent the most common indolent forms of CTCL.
  • Diagnosis can be delayed, with patients experiencing symptoms for extended periods.

Purpose of the Study:

  • To summarize the characteristics and prognosis of primary cutaneous T-cell lymphomas.
  • To highlight the differences in outcomes between early-stage disease and transformed lymphoma.

Main Methods:

  • Review of existing literature on CTCL.
  • Analysis of patient data regarding disease progression and survival.

Main Results:

Related Experiment Videos

  • CTCLs are slow-growing and uncommon, affecting fewer than 1,000 individuals annually.
  • Early-stage T1 disease is associated with a normal life expectancy.
  • Transformation to large cell lymphoma occurs in 8%-23% of patients, leading to a poor prognosis with a mean survival of 2-19 months.

Conclusions:

  • Prognosis for CTCL is highly dependent on disease stage and transformation status.
  • Early detection and management are crucial for improving outcomes in CTCL patients.